Clinical Trial Update: Penicillamine Chelation for Children With Lead Poisoning [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of penicillamine chelation for children with lead poisoning has been withdrawn; no trial results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lead Poisoning
• Vitamin Deficiency

Drugs mentioned

• Penicillamine (Penicillamine)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Lead Poisoning, Vitamin D Deficiency | Phase 2, Phase 3 | Status: WITHDRAWN